Quality and Regulatory Sourcebook eBook March 2023
Read the article:
Evolution of Analytical Procedure Validation Concepts: Part II
Read Part I:
Evolution of Analytical Procedure Validation Concepts: Part I
Read the eBook:
Evolution of Analytical Procedure Validation Concepts: Part II
Publication
Article
BioPharm InternationalBioPharm International Quality and Regulatory Sourcebook 2023
Volume 2023 eBook
Issue 1
Pages: 22–29
This article focuses on drawing parallels between ICH Q14/Q2(R2), United States Pharmacopeia (USP) <1220>, and International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017.
Worawut - Stock.adobe.com
In parallel to the evolution of compendial and regulatory approaches addressing new quality paradigms for analytical procedure validation (discussed in Part I of this article), fundamentals of the quality-by-design (QbD) concept have been incorporated into the new International Council for Harmonisation (ICH) Q14 and ICH Q2(R2), which were recently released for public consultation. This article focuses on drawing parallels between ICH Q14/Q2(R2), United States Pharmacopeia (USP) <1220>, and International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017.
Read the article in BioPharm International’s Quality and Regulatory Sourcebook March 2023
About the authors
Amanda Guiraldelli is scientific affairs manager at the United States Pharmacopeia.
Jane Weitzel is an independent consultant and chair of the US Pharmacopeia Expert Committee on Measurement and Data Quality.
Article details
BioPharm International
eBook: Quality and Regulatory Sourcebook 2023
March 2023
Pages: 22–29
Citation
When referring to this article, please cite it as Guiraldelli, A. and Weitzel, J. Evolution of Analytical Procedure Validation Concepts: Part 2. BioPharm International Quality and Regulatory Sourcebook 2023. March 2023.
Articles in this issue
Mitigating Human Error and Supporting Compliance with Smart Technology
Phase-appropriate Analytical Methodology
Evolution of Analytical Procedure Validation Concepts: Part II
Pharmacovigilance Automation
Evolution of Analytical Procedure Validation Concepts: Part I
Points to Consider for Knowledge Management Acceleration
Recent Videos
Related Content
Regeneron Treatment for Multiple Myeloma Gets Conditional Marketing Approval from EC
April 29th 2025Article
The indication is specific to patients who have received at least three prior therapies, including a proteasome inhibitor, immunomodulatory agent, and anti-CD38 monoclonal antibody, and have demonstrated disease progression on the last therapy.
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Article
Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.
